No one is questioning if it will work, because it does. The issue is will RGIN be the one to take to market and get FDA approval. Have no cash and need to raise money, (hard to do when a penny stock) legal issues, etc.. Who are they competing against. What about the other 12 firms that LONZA licensed product too? Or what about MERCK or Pfizer or anyone else. With no news it is frustrating, besides the 10Q of course. Was also frustrating to see them reduce option price from 68 cents to 3.5 cents for insiders, that was a no confidence vote in my book.
News 
Market Data 
Discover 
